GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (STU:08HH) » Definitions » Change In Prepaid Assets

Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Change In Prepaid Assets : €0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Change In Prepaid Assets?

Shanghai Fosun Pharmaceutical (Group) Co's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was €0 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co's Prepaid Assets stayed the same from Dec. 2024 to Mar. 2025 .

Shanghai Fosun Pharmaceutical (Group) Co's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was €0 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co's Prepaid Assets stayed the same from Dec. 2023 to Dec. 2024 .

Shanghai Fosun Pharmaceutical (Group) Co Change In Prepaid Assets Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Change In Prepaid Assets Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shanghai Fosun Pharmaceutical (Group) Co Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (STU:08HH) » Definitions » Change In Prepaid Assets
Comparable Companies
SZSE:000999 SHSE:600085 SZSE:002001 SZSE:000661 SZSE:000963 SZSE:000423 SHSE:600079 SZSE:000513 SZSE:002773 SHSE:600518 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
SFOSF:USA 02196:Hong Kong 600196:China
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Website
https://www.fosunpharma.com
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers mergers and acquisitions as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines